Longeveron Inc.
LGVNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for LGVN. That does not mean none is planned.
Get an email about LGVN's next catalysts
Track Longeveron (LGVN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Lomecel-B medicinal signaling cells
Hypoplastic Left Heart Syndrome
Fluzone High Dose Vaccine
Aging Frailty
Allogeneic MSC
Mild Alzheimer's Disease
Longeveron Mesenchymal Stem Cells (LMSCs)
Aging Frailty
Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)
Frailty
Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)
Frailty
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Lomecel-B medicinal signaling cells | Phase 2 | Hypoplastic Left Heart Syndrome | - | - |
Fluzone High Dose Vaccine | Phase 2 | Aging Frailty | - | - |
Allogeneic MSC | Phase 2 | Mild Alzheimer's Disease | - | - |
Longeveron Mesenchymal Stem Cells (LMSCs) | Phase 2 | Aging Frailty | - | - |
Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) | Phase 2 | Frailty | - | - |
Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) | Phase 2 | Frailty | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Longeveron Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Longeveron Inc.'s (LGVN) pipeline across Phase 2. Its lead program is Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Longeveron Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Longeveron Inc. (LGVN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LGVN biotech catalysts?→
Add LGVN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Longeveron Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.